Combination therapy for the treatment of ocular neovascular disorders

Details for Australian Patent Application No. 2010224423 (hide)

Owner Ophthotech Corporation

Inventors Adamis, Anthony P.; Shima, David; Calias, Perry

Agent Spruson & Ferguson

Pub. Number AU-B-2010224423

Parent 2004268614

Filing date 24 September 2010

Wipo publication date 14 October 2010

Acceptance publication date 6 September 2012

International Classifications

A61K 31/00

A61K 31/52

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61K 38/00 Medicinal preparations containing peptides

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

14 October 2010 Application Open to Public Inspection

  Published as AU-B-2010224423

14 October 2010 Complete Application Filed

6 September 2012 Application Accepted

  Published as AU-B-2010224423

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224424-Methods and devices for multi-state card games with card replacement

2010224422-Pneumatic compression garment with noise attenuating means